Association between BRAF(V600E) mutation and the clinicopathological features of solitary papillary thyroid microcarcinoma

The B-Raf proto-oncogene serine/threonine kinase (BRAF)(V600E) mutation is an important oncogene in the development of papillary thyroid carcinoma (PTC) and has been identified as a risk factor for poor prognosis in patients with PTC. However, whether the BRAF(V600E) mutation is a prognostic marker...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Hai-Zhen, Qiu, Tian, Ying, Jian-Ming, Lyn, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403221/
https://www.ncbi.nlm.nih.gov/pubmed/28454296
http://dx.doi.org/10.3892/ol.2017.5661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403221/
https://www.ncbi.nlm.nih.gov/pubmed/28454296
http://dx.doi.org/10.3892/ol.2017.5661

Ejemplares similares